Back
Inari Medical Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer2.jpg)
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Buy
57
NARI
Inari Medical
Last Price:
55.13
Seasonality Move:
7.11%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer18.jpg)
New Study Says Thursday Is The Best Day To Trade TSLA Shares
Click here for detailsInari Medical Price Quote
$55.13
+0.23 (+0.42%)
(Updated: July 22, 2024 at 12:45 PM ET)
Inari Medical Key Stats
Buy
57
Inari Medical (NARI)
is a Buy
Day range:
$53.72 - $55.47
52-week range:
$36.73 - $71.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.13
P/B ratio:
7.14%
Volume:
617.9K
Avg. volume:
725K
1-year change:
-2.59%
Market cap:
$3.2B
Revenue:
$493.6M
EPS:
$-0.41
How Much Does Inari Medical Make?
-
How Much Are Inari Medical's Sales Annually?
NARI Revenues are $493.6M -
How Much Profit Does Inari Medical's Make A Year?
NARI net income is -$1.6M
Is Inari Medical Growing As A Company?
-
What Is Inari Medical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.23% -
What Is Inari Medical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Inari Medical Stock Price Performance
-
Did Inari Medical Stock Go Up Last Month?
Inari Medical share price went up by 20.85% last month -
Did NARI's Share Price Rise Over The Last Year?
NARI share price fell by -2.59% over the past 1 year
What Is Inari Medical 52-Week High & Low?
-
What Is Inari Medical’s 52-Week High Share Price?
Inari Medical has traded as high as $71.85 over the past 52 weeks -
What Is Inari Medical’s 52-Week Low Share Price?
Inari Medical has traded as low as $36.73 over the past 52 weeks
Inari Medical Price To Free Cash Flow
-
Is Inari Medical Stock Overvalued?
Inari Medical is trading at a price to free cash flow ratio of 172.57 -
Is Inari Medical Stock Undervalued?
Inari Medical EV to Free Cash Flow ratio is 167.01 -
What Is Inari Medical’s Price Earnings Growth Ratio?
NARI PEG ratio is 0.00 -
Is Inari Medical Trading At A Premium To Earnings?
Inari Medical EV to EBIT ratio is 0.00
Is It Risky To Buy Inari Medical?
-
How Much Debt Does Inari Medical Have?
Total long term debt quarterly is $0 -
How Much Cash Does Inari Medical Have?
Cash and short term investments quarterly total is $101.3M -
What Is Inari Medical’s Book Value Per Share?
Book value per share is 7.71
Is Inari Medical Cash Flow Positive?
-
What Is NARI Cash Flow From Operations?
Cash flow from operations (TTM) is $25.7M -
What Is Inari Medical’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$280K -
What Is Inari Medical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$14.8M
Inari Medical Return On Invested Capital
-
Is Management Doing A Good Job?
NARI return on invested capital is -5.3% -
What Is Inari Medical Return On Assets?
ROA measures how assets are converting to revenues and is -4.05% -
What Is NARI Return On Equity?
ROE is a measure of profitability and is -5.3%
Inari Medical Earnings Date & Stock Price
-
What Is Inari Medical's Stock Price Today?
A single share of NARI can be purchased today for 54.90 -
What Is Inari Medical’s Stock Symbol?
Inari Medical trades on the nasdaq under the ticker symbol: NARI -
When Is Inari Medical’s Next Earnings Date?
The next quarterly earnings date for Inari Medical is scheduled on July 30, 2024 -
When Is NARI's next ex-dividend date?
Inari Medical's next ex-dividend date is July 22, 2024 -
How To Buy Inari Medical Stock?
You can buy Inari Medical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Inari Medical Competitors
-
Who Are Inari Medical's Competitors?
Below is a list of companies who compete with Inari Medical or are related in some way:
Inari Medical Dividend Yield
Data Unavailable
Inari Medical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -172.5% |
Revenue: | 23.27% | 3.95% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 66.90 |
Upside from Last Price: | 21.86% |